Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factors and melanomas

R Halaban1

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, CT 06520-8059, USA.

Seminars in Oncology
|December 1, 1996
PubMed
Summary

Understanding normal melanocyte growth helps identify melanoma's growth advantage. Basic fibroblast growth factor (bFGF/FGF2) and cell cycle regulators like cyclin-dependent kinases (CDKs) are key in melanoma development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

AMPK promotes tolerance to Ras pathway inhibition by activating autophagy.

Oncogene·2016
Same author

A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.

Oncogene·2010
Same author

Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine.

The Journal of biological chemistry·2001
Same author

Translation rate of human tyrosinase determines its N-linked glycosylation level.

The Journal of biological chemistry·2000
Same author

Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Normal human melanocyte growth is regulated by synergistic growth factors, including fibroblast growth factors (FGF), hepatocyte growth factor/scatter factor, mast/stem cell growth factor, and endothelin peptides (ET-1, ET-2, ET-3).
  • Melanoma cells exhibit altered growth factor signaling and cell cycle control, contributing to their uncontrolled proliferation.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the growth advantage of melanoma cells compared to normal melanocytes.
  • To identify key growth factors and cell cycle regulators involved in melanoma progression.

Main Methods:

  • Analysis of growth factor expression and signaling pathways in melanoma cells.
  • Investigation of cell cycle regulatory proteins, including cyclin-dependent kinases (CDKs) and their inhibitors.
  • Assessment of the role of p53 in regulating gene expression related to growth factor signaling.

Main Results:

  • Basic fibroblast growth factor (bFGF/FGF2) is implicated in the autonomous growth of melanoma cells, potentially via activation of a repressed gene involving wild-type p53.
  • Aberrantly expressed growth factors and activated receptors in melanoma cooperate with cell cycle machinery.
  • Constitutive activity of cyclin-dependent kinase 4 (CDK4) in melanomas results from the inactivation of CDK inhibitors (p16INK4, p21) and/or overexpression of cyclin D.

Conclusions:

  • Melanoma cells overcome normal growth constraints through a complex interplay of aberrant growth factor signaling and dysregulated cell cycle progression.
  • The activation of FGF2 and constitutive CDK4 activity are critical events enabling uncontrolled cell proliferation in melanoma.
  • Targeting these pathways may offer therapeutic strategies for melanoma treatment.

Related Experiment Videos